{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:04:55Z","timestamp":1790053495704,"version":"4.0.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"\n Introduction<\/jats:title>\n To evaluate the association of Platelet Function Testing (PFT)-guided intensified antiplatelet strategy with the incidence of thromboembolic events and bleeding rates in patients with Unruptured Intracranial Aneurysms (UIA) undergoing stent-assisted coil embolization, compared with standard fixed-dose Dual Antiplatelet Therapy (DAPT).<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n In this retrospective study, 368 patients from two centers between January 2019 and September 2024 were enrolled and categorized into a Monitored Group (\n n<\/jats:italic>\n \u202f=\u202f219) and a Non-monitored Group (\n n<\/jats:italic>\n \u202f=\u202f149). Both groups initially received a fixed-dose DAPT regimen of clopidogrel 75\u202fmg and aspirin 100\u202fmg daily. Within 24\u202fh prior to the procedure, the Monitored Group underwent PFT. Patients exhibiting High On-Treatment Platelet Reactivity (HPR) to clopidogrel were administered a single 300\u202fmg clopidogrel loading dose and received short-term perioperative tirofiban. For patients with HPR to aspirin, the aspirin dose was increased to 200\u202fmg daily. The Non-monitored Group did not undergo platelet function testing and dose adjustment. To control for confounding, propensity score matching (PSM) and multivariable Cox regression were performed. The primary outcome was the composite thromboembolic event rate within 7\u202fdays post-procedure. Secondary outcomes included the composite thromboembolic event rate within 30\u202fdays, and the safety outcome was the composite bleeding event rate within 30\u202fdays.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In the original cohort, the monitored strategy was associated with a lower incidence of the primary 7-day composite thromboembolic outcome (3.20% vs. 8.05%; unadjusted HR\u202f=\u202f0.388, 95%CI 0.153\u20130.985,\n p<\/jats:italic>\n \u202f=\u202f0.045; adjusted HR\u202f=\u202f0.391, 95%CI 0.154\u20130.994,\n p<\/jats:italic>\n \u202f=\u202f0.048). The association remained directionally consistent in the propensity score-matched cohort (115 pairs, 4.35% vs. 8.70%; HR\u202f=\u202f0.487, 95%CI 0.166\u20131.424,\n p<\/jats:italic>\n \u202f=\u202f0.189). The secondary 30-day composite thromboembolic outcome showed similar patterns (original cohort: adjusted HR\u202f=\u202f0.412, 95%CI 0.187\u20130.909,\n p<\/jats:italic>\n \u202f=\u202f0.028; PSM cohort: HR\u202f=\u202f0.446, 95%CI 0.169\u20131.172,\n p<\/jats:italic>\n \u202f=\u202f0.101). No statistically significant association was observed for the 30-day composite bleeding event rates between the two groups in either the original or matched analyses. Subgroup analyses identified no significant association modifiers.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n A PFT-guided intensified antiplatelet strategy was associated with a lower incidence of early post-procedural thromboembolic events without a significant increase in major bleeding in UIA patients treated with EP2 stent-assisted coiling. These findings support the potential utility of this comprehensive strategy, although the independent contribution of each component requires further investigation in larger prospective studies.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fneur.2026.1829631","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:23:23Z","timestamp":1790051003000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of a platelet function testing-guided intensified antiplatelet strategy with thromboembolic events after EP2 stent-assisted coil embolization in patients with unruptured intracranial aneurysms"],"prefix":"10.3389","volume":"17","author":[{"given":"Jinan","family":"Bai","sequence":"first","affiliation":[{"name":"Neurosurgery Department of Yangzhou Hongquan Hospital","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Neurosurgery Department of Yangzhou Hongquan Hospital","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ailiang","family":"Ge","sequence":"additional","affiliation":[{"name":"Neurosurgery Department of Yangzhou Hongquan Hospital","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Sun","sequence":"additional","affiliation":[{"name":"Neurosurgery Department of Yangzhou Hongquan Hospital","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjia","family":"Yang","sequence":"additional","affiliation":[{"name":"Neurosurgery Department of Yangzhou Hongquan Hospital","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Liang","sequence":"additional","affiliation":[{"name":"Neurosurgery Department of Yangzhou Hongquan Hospital","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Northern Jiangsu People\u2019s Hospital Afffliated to Yangzhou University","place":["Yangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e42265","DOI":"10.1097\/MD.0000000000042265","article-title":"Current status and prospects of endovascular treatment for intracranial vertebral artery aneurysms: a narrative review","volume":"104","author":"Qu","year":"2025","journal-title":"Medicine (Baltimore)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/STROKEAHA.123.046208","article-title":"ARISE I consensus review on the Management of Intracranial Aneurysms","volume":"55","author":"Tjoumakaris","year":"2024","journal-title":"Stroke"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.2147\/VHRM.S499465","article-title":"Large and Giant intracranial aneurysm: surgical management and outcomes in a tertiary hospital","volume":"21","author":"Barbarawi","year":"2025","journal-title":"Vasc Health Risk Manag"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"589689","DOI":"10.3389\/fneur.2020.589689","article-title":"The Enterprise2 stent for endovascular treatment of intracranial aneurysms: short-term results from a single center experience","volume":"11","author":"Chen","year":"2020","journal-title":"Front Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s41016-022-00298-w","article-title":"Effects of Enterprise 2 stent-assisted coil embolization for wide-necked intracranial aneurysms","volume":"8","author":"Zhou","year":"2022","journal-title":"Chin Neurosurg J"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"922858","DOI":"10.3389\/fcvm.2022.922858","article-title":"Predictors of thromboembolic complications after stent-assisted coiling of acutely ruptured intracranial aneurysms: a retrospective multicenter study","volume":"9","author":"Li","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3760\/cma.j.issn.1673-4165.2021.09.002","article-title":"Chinese expert consensus on antiplatelet therapy for intracranial aneurysms","volume":"29","year":"2021","journal-title":"Int J Cerebrovasc Dis"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/jnis-2023-020285","article-title":"Optimal duration of dual antiplatelet therapy for stent-assisted coiling or flow diverter placement","volume":"16","author":"Enomoto","year":"2024","journal-title":"J Neurointerv Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"108602","DOI":"10.1016\/j.clineuro.2024.108602","article-title":"Efficacy and safety of intravenous tirofiban versus standard medical treatment in acute ischemic stroke: a meta-analysis of randomized controlled trials","volume":"247","author":"Monteiro","year":"2024","journal-title":"Clin Neurol Neurosurg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/s10143-025-03601-2","article-title":"Prophylactic administration of tirofiban prevents ischemic events in endovascular treatment of unruptured intracranial aneurysms","volume":"48","author":"Yao","year":"2025","journal-title":"Neurosurg Rev"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1055\/a-2347-4221","article-title":"Risk factors, antithrombotic management, and long-term outcomes of patients undergoing endovascular treatment of Unruptured intracranial aneurysms","volume":"125","author":"Xiang","year":"2025","journal-title":"Thromb Haemost"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00234-016-1742-6","article-title":"Safety and efficacy of antiplatelet response assay and drug adjustment in coil embolization: a propensity score analysis","volume":"58","author":"Kim","year":"2016","journal-title":"Neuroradiology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3174\/ajnr.A7923","article-title":"Effect of platelet function testing guidance on clinical outcomes for patients with intracranial aneurysms undergoing endovascular treatment","volume":"44","author":"Wang","year":"2023","journal-title":"Am J Neuroradiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e241509","DOI":"10.1148\/radiol.241509","article-title":"Guided antiplatelet therapy for stent-treated intracranial aneurysms: a cluster-randomized trial","volume":"314","author":"Zhou","year":"2025","journal-title":"Radiology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1007\/s12975-023-01171-3","article-title":"Use of tirofiban to prevent ischemic events in patients with CYP2C19 loss-of-function alleles during flow diversion of intracranial aneurysm: a multicenter cohort study","volume":"15","author":"Zhou","year":"2023","journal-title":"Transl Stroke Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3760\/cma.j.cn112137-20240222-00373","article-title":"Chinese guideline for the clinical management of patients with unruptured intracranial aneurysms (2024)","volume":"104","year":"2024","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.7754\/clin.lab.2013.131004","article-title":"Detection of clopidogrel resistance using ADP induced aggregometry with specific inhibitor PGE1","volume":"60","author":"Slavik","year":"2014","journal-title":"Clin Lab"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/eurheartj\/eht375","article-title":"Expert position paper on the role of platelet function testing in patients undergoing percutaneous coronary intervention","volume":"35","author":"Aradi","year":"2014","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1136\/svn-2022-001720","article-title":"Roles of light transmission aggregometry and CYP2C19 genotype in predicting ischaemic complications during interventional therapy for intracranial aneurysms","volume":"8","author":"Zhou","year":"2023","journal-title":"Stroke Vasc Neurol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S0735-1097(02)03014-0","article-title":"A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease","volume":"41","author":"Gum","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-med-050823-094312","article-title":"Contemporary Management of Acute Ischemic Stroke","volume":"76","author":"Ho","year":"2025","journal-title":"Annu Rev Med"},{"key":"ref22","article-title":"Transient ischemic attack","volume-title":"StatPearls [Internet]","author":"Panuganti","year":"2025"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0735-1097(88)90158-1","article-title":"Thrombolysis in myocardial infarction (TIMI) trial\u2014phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase","volume":"11","author":"Rao","year":"1988","journal-title":"J Am Coll Cardiol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3978\/j.issn.2223-3652.2013.02.03","article-title":"High residual platelet reactivity on clopidogrel: its significance and therapeutic challenges overcoming clopidogrel resistance","volume":"3","author":"Garabedian","year":"2013","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40265-019-01078-0","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibitor Tirofiban in acute ischemic stroke","volume":"79","author":"Yang","year":"2019","journal-title":"Drugs"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e70508","DOI":"10.1002\/brb3.70508","article-title":"Tirofiban combination therapy for acute ischemic stroke: a systematic review and meta-analysis","volume":"15","author":"Kamran","year":"2025","journal-title":"Brain Behav"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.actbio.2019.08.042","article-title":"Endothelialization of cardiovascular devices","volume":"99","author":"Jana","year":"2019","journal-title":"Acta Biomater"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"e002436","DOI":"10.1136\/openhrt-2023-002436","article-title":"Role of genetic polymorphisms in clopidogrel response variability: a systematic review","volume":"10","author":"Lopez","year":"2023","journal-title":"Open Heart"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00228-025-03860-4","article-title":"Comparison between clopidogrel and ticagrelor in CYP2C19 loss-of-function alleles coronary artery disease and stroke patients: a meta-analysis","volume":"81","author":"Elsayed","year":"2025","journal-title":"Eur J Clin Pharmacol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"27399","DOI":"10.1038\/s41598-025-11882-2","article-title":"Evaluation of safety and efficacy of Tirofiban injection for treating acute ischemic stroke beyond standard time window","volume":"15","author":"Yang","year":"2025","journal-title":"Sci Rep"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1177\/1747493016677989","article-title":"Intravenous administration of tirofiban versus loading dose of oral clopidogrel for preventing thromboembolism in stent-assisted coiling of intracranial aneurysms","volume":"12","author":"Zi-Liang","year":"2017","journal-title":"Int J Stroke"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1622235","DOI":"10.3389\/fcvm.2025.1622235","article-title":"Stent thrombosis: a contemporary guide to definitions, risk factors, and management","volume":"12","author":"Flowers","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1161\/strokeaha.120.032989","article-title":"Effect of adjusted antiplatelet therapy on preventing ischemic events after stenting for intracranial aneurysms","volume":"52","author":"Li","year":"2021","journal-title":"Stroke"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/MNJY9014","article-title":"Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies","volume":"27","author":"Harris","year":"2023","journal-title":"Health Technol Assess"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jcin.2020.12.005","article-title":"Stent thrombosis risk over time on the basis of clinical presentation and platelet reactivity: analysis from ADAPT-DES","volume":"14","author":"Chau","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/eurheartj\/ehv104","article-title":"Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention","volume":"36","author":"Aradi","year":"2015","journal-title":"Eur Heart J"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e015439","DOI":"10.1161\/JAHA.119.015439","article-title":"Relationship between platelet reactivity and ischemic and bleeding events after percutaneous coronary intervention in east Asian patients: 1-year results of the PENDULUM registry","volume":"9","author":"Nakamura","year":"2020","journal-title":"J Am Heart Assoc"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1829631\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:23:26Z","timestamp":1790051006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1829631\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":37,"alternative-id":["10.3389\/fneur.2026.1829631"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1829631","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1829631"}}